Biocurcumin BCM95® Enhances Curcumin’s Anticancer Efficacy in Integrative Cancer Care

Curcumin is the primary bioactive compound in turmeric. Extensive research has been conducted to uncover the wide-ranging health benefits of curcumin, with thousands of publications on cancer alone. However, curcumin’s bioavailability is extremely low, severely limiting its health benefits in humans. Scientists then designed BCM95, a patented formulation that combines curcumin with turmeric essential oils to improve absorption. This formulation has demonstrated a 7-fold higher bioavailability (when taken orally) compared to standard curcumin in humans.

With BCM95, curcumin’s anticancer effects become far more effective. The literature shows that curcumin has multiple anticancer mechanisms, of which the two main ones are (i) catalysing the apoptotic pathway to cause programmed cell death and (ii) stopping the NF-κB pro-inflammatory pathway to reduce cancer growth. Curcumin also has targeted effects against specific cancers, such as blocking the human epidermal growth factor receptor 2 (HER2) in breast cancer and inhibiting androgen receptors in prostate cancer cells. As these receptor targets are key drivers of tumour growth, interfering with them may help limit cancer spread and improve treatment outcomes.

Numerous randomised clinical trials on curcumin or BCM95 have been done on cancer patients, with no significant safety issues so far. Compared to placebo, two separate trials showed that oral curcumin decreased the levels of prostate-specific antigen (PSA), the main biomarker of prostate cancer growth. In another placebo-controlled trial, prostate cancer patients who took oral BCM95 experienced fewer urinary side effects from radiotherapy. (Radiotherapy uses ionising radiation to kill cancer cells, which can also damage nearby healthy tissues, leading to side effects in the treated area.) Four separate trials have shown that oral or topical (cream) curcumin reduced the severity of radiotherapy-induced dermatitis (i.e., skin irritation) in breast cancer patients. Together, these findings underscore BCM95 as a promising and safe curcumin formulation that helps improve clinical outcomes and the quality of life of cancer patients.

For readers interested in the broader health effects of this plant, we explore them in more detail here.